Preferred Label : evenity;
Origin ID : M000653518;
False automatic mappings
- Manual NTBT mappings (CISMeF)
- Related record
https://www.has-sante.fr/jcms/p_3243905/fr/evenity
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
romosozumab
guidelines for drug use
osteoporosis, postmenopausal
osteoporotic fractures
aged
risk assessment
injections, subcutaneous
evenity
Product containing only romosozumab in parenteral dose form (medicinal product form)
evaluation of the transparency committee
romosozumab
romosozumab
antibodies, monoclonal
antibodies, monoclonal
---
https://www.ema.europa.eu/en/medicines/human/EPAR/evenity
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
romosozumab
osteoporotic fractures
osteoporosis, postmenopausal
adult
aged
injections, subcutaneous
SOST protein, human
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical
evenity
Product containing only romosozumab in parenteral dose form (medicinal product form)
romosozumab
romosozumab
antibodies, monoclonal
antibodies, monoclonal
genetic markers
bone morphogenetic proteins
---
